Jianjun Wang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 13
- Ubiquitin and proteasome pathways 4
- 14-3-3 protein interactions 4
-
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 9
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Feng Zhao (5 shared papers)Kai Fan (12 shared papers)Ke Jiang (8 shared papers)Guanghai Yang (4 shared papers)Quanchao Sun (4 shared papers)Quan Liu (2 shared papers)Jiguang Zhang (1 shared paper)Li Wan (2 shared papers)
- Journals
- Archives of Biochemistry and Biophysics (2 papers)Biochemical and Biophysical Research Communications (2 papers)Nature Communications (2 papers)European Journal of Pharmacology (2 papers)OncoTargets and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jianjun Wang
84 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 1.2k
- Molecular Biology 1.7k
- Biotechnology 103
- Biochemistry 67
- Immunology 183
Countries citing papers authored by Jianjun Wang
This map shows the geographic impact of Jianjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Wang more than expected).
Fields of papers citing papers by Jianjun Wang
This network shows the impact of papers produced by Jianjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Wang. The network helps show where Jianjun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianjun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 483 | |
| 2 | 2016 | 289 | |
| 3 | 2018 | 212 | |
| 4 | 2009 | 207 | |
| 5 | 2017 | 170 | |
| 6 | 2003 | 117 | |
| 7 | 2017 | 82 | |
| 8 | 2018 | 70 | |
| 9 | 2014 | 67 | |
| 10 | 2017 | 65 | |
| 11 | 2021 | 59 | |
| 12 | 2017 | 52 | |
| 13 | 2019 | 52 | |
| 14 | 2004 | 51 | |
| 15 | 2016 | 49 | |
| 16 | 2020 | 48 | |
| 17 | XBP1 induces MMP-9 expression to promote proliferation and invasion in human esophageal squamous cell carcinoma. | 2016 | 42 |
| 18 | 2021 | 40 | |
| 19 | 2017 | 38 | |
| 20 | 2017 | 36 |
About Jianjun Wang
Jianjun Wang is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Immunology, having authored 89 papers that have together received 2.9k indexed citations. Recurring topics across this work include Circular RNAs in diseases (13 papers), MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (9 papers), Transplantation: Methods and Outcomes (6 papers), Lipid metabolism and biosynthesis (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Ubiquitin and proteasome pathways (4 papers) and 14-3-3 protein interactions (4 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.7k citations), Biotechnology (103 citations), Biochemistry (67 citations) and Immunology (183 citations). Jianjun Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Feng Zhao, Kai Fan, Ke Jiang, Guanghai Yang, Quanchao Sun, Quan Liu, Jiguang Zhang, Li Wan, Lin Zhang and Zaixing Cheng. Their work appears in journals such as Archives of Biochemistry and Biophysics, Biochemical and Biophysical Research Communications, Nature Communications, European Journal of Pharmacology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.